Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide
Patent 6805883 Issued on October 19, 2004. Estimated Expiration Date: June 19, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
424/725, PLANT MATERIAL OR PLANT EXTRACT OF UNDETERMINED CONSTITUTION AS ACTIVE INGREDIENT (E.G., HERBAL REMEDY, HERBAL EXTRACT, POWDER, OIL, ETC.)424/776, Containing or obtained from a seed or nut424/400, PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM424/439, Food or edible as carrier for pharmaceutical426/45, Coffee or cocoa, e.g., coffee extract, etc.424/48, CHEWING GUM TYPE426/244, Involving dielectric heating or passage of electric current through food material426/94, Dough or batter type426/93, Isolated whole seed, bean or nut, or material derived therefrom426/565, Frozen514/844, COSMETIC, FACIAL514/2, Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI514/396, Imidazoles514/21, Produced by or extracted from animal tissue514/18, 3 or 4 peptide repeating units in known peptide chain514/565, N-N or N=C(-N)-N containing (e.g., hydrazines, hydrazones, or quanidines, etc.)514/561, Nitrogen other than as nitro or nitroso nonionically bonded514/557, Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.)514/15, 9 to 11 peptide repeating units in known peptide chain424/401, Cosmetic, antiperspirant, dentifrice426/660, Confection514/453, Polycyclo ring system having the hetero ring as one of the cyclos439/136, Movably mounted426/656Protein, amino acid, or yeast containing
Foods and pharmaceuticals which contain cocoa and/or nut procyanidin(s) in combination with L-arginine are effective to induce a physiological increase in nitric oxide production in a mammal having ingested the product. A preferred food product is a confection, particularly a dark or milk chocolate containing nuts. The procyanidins may be natural or synthetic and may be provided by food ingredients such as chocolate liquor and/or cocoa solids prepared from underfermented beans and nut skins. The L-arginine may be natural or synthetic and may be provided by food ingredients such as nut meats, nut pastes, and/or nut flours, seeds, seed pastes, and/or seed flours, or gelatin. The beneficial health effects may include, for example, reduced blood pressure, resistance to cardiovascular disease, and anticancer activity.
Other References
U.S. patent application Ser. No. 08/831,245, Romanczyk et al., filed Apr. 12, 1997.
Snyder, S.H. et al, Scientific American 68-77, (May 1992).
Feldman, P.L., et al, Chem. and Eng. News 26-28 (1993).
Wheeler, M.A., et al, J. Urology 158:2045-2050 (1997).
Boger, R.H., et al, Atherosclerosis 141:31-43 (1998).
Chowlenczyk, et al, The Lancet, 350:901-30, (1997).
Clarkson, P. et al., J. Clin. Invest. 97:8, 1989-1994 (1996).
Engel et al, J.C.S. Chem. Comm. (1978).
Escribano-Bailon, et al, Phytochemistry 41:6, 1583-1592 (1996).
Fitzpatrick, D.F., et al, Am. J. Physiol. 265 (Heart Circ. Physiol. 34) H774-778 (1993).
Tenenbaum, A, et al, Cardiology 90:153-159 (1998).
Sabate, J. et al, New England J. Med. 328:03-607 (1993).
Sabate, J. et al, Lipidology 5:11-16 (1994).
Cooke et al, Circulation 83:1057-1062 (1991).
Hammerstone, J. et al, J. Agric. Food Chem. 47, 2:490-6 (1999).
Clapperton et al, Proceedings, 16th International Conference of Groupe Polyphenols, Tome II:112-115.
Lazarus et al, Submitted to J. Agric. Food Chem.
Jalal et al, Phytochemistry 16:1377-1380 (1997).
Meyer et al, J. Agric. Food. Chem. 45:1638-1643 (1997).
Saito et al, J. Agric. Food Chem. 46:1460-1465 (1998).
Waterhouse et al, Nutrition of Grape Phenolics.
Faraci et al, Stroke, 25:3, 692-703 (1994).
Moritoki, H., Ueda, H, Yamamoto, T., Hisayama, T., Takeuchi, S. Br. J. Pharmacol., 102:841-846 (1991).
Kim et al., J. Food Science, 49:1090-1092, (1984).
Klahr, S., Current opinions in Nephrology and hypertension, 7:547-550 (1998).
Vercauteren, J. Polyphenols 94: 29-44, (1994).
McMamara et al., “L-Arginine Inhibits Battery Catheter-Induced Intimal Hyperplasts”, pp. 291-296, (1993).
Sahare et al., “Effects of Walnuts on Serum Lipid Levels and Blood Pressure in Normal Men”, New England Journal of Medicine, 1993, 328:603-607.
Sabaté{acute over ( )} et al., “Nuts: a new protective food against coronary heart disease”, Current Opinion in Lipidology, 1994, 5:11-16.
Rossitch, Jr., “L-Arginine Normalizes Endothelial Function in Cerebral Vessels from Hypercholesterolemic Rabbits”, J. Clin. Invest., 1991, 87:1295-1299.
Jia et al., “S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control”, Nature, 1996, 380:221-226.
“Arginine: NO more than a simple amino acid?”, The Lancet, 1997, 350:901-902.
Girerd, et al., “L-Arginine Augments Endothelium-Dependent Vasodilation in Cholesterol-Fed Rabbits”, Circulation Research, 1990, 67:6 1301-1308.
Drexler et al., “Correction of ektothelial dysfunction in coronary microcirculation of hypercholesterolacemic patients by L-arginine”, The Lancet, 1991, 338:1546-1550.
Creager et al., “L-Arginine Improves Endothelium-dependent Vasodilation in Hypercholesterolemic Humans”, J. Clin. Invest., 1992, 90:1248-1253.
Cooke, et al. “Arginine Restores Cholinergic Relaxation of Hypercholesterolemic Rabbit Thoracic Aorta”, Circulation, 1991, 83:3 1057-1062.
Cooke, et al., “Anti-Atherogenic Effect of Nuts: Is the Answer NO?”, Arch Intern Med, 1993, 153:896, 899.
June 19, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
